FDA Healthcare Prescription Safety 
World of DTC Marketing
JUNE 24, 2021
Safety pages on Pharma product websites continue to have high utility. Prescription drugs are not the same as items found in a grocery store. People don’t see an ad for a prescription drug and say, “oh, I need that!” More importantly, the FDA needs to work with online sites to eliminate health misinformation.
PM360
SEPTEMBER 15, 2022
In many of the states where abortion is banned, strictly regulated, or soon to be restricted, the procedure is legal only in instances of a life-threatening situation, but no regulations define what such a situation may be, leaving 70% of physicians unclear about when to intervene for maternal safety. FDA Update. Drug Approvals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
OCTOBER 13, 2023
Of the eight FDA-approved weight loss drugs on the market, these two are making waves for doctors who believe they represent “a new era for weight loss medications,” and “changing options and giving hope.” “They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP).
World of DTC Marketing
APRIL 12, 2021
We need a 21st-century approach that puts patient safety first. The US Food and Drug Administration (FDA) believes the adulteration of heparin was an economically motivated act—a clear breach of the US pharmaceutical supply chain. In other words, money over safety. Supply chain issues in healthcare are damn scary.
pharmaphorum
OCTOBER 12, 2018
Digital technology is transforming the way that healthcare is practiced and delivered, with areas like digital therapeutics forging ahead to complement traditional medical approaches and augment patient care.
Pharmaceutical Technology
JANUARY 31, 2023
FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. This “skinny” bill passed just in time to continue funding the FDA, with few of the planned amendments. billion in funding, a $226 million increase on the previous year.
European Pharmaceutical Review
NOVEMBER 8, 2022
In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. Citizen Petitions before the FDA. 2 Submission of a Citizen Petition to the FDA obligates the regulator to address the arguments raised. 5) monitoring access to biosimilars. Senate Bill 562 (S.
Expert insights. Personalized for you.
165 
Let's personalize your content